Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
107.07
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi
August 02, 2021
Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi
Via
News Direct
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
July 31, 2021
Rani Therapeutics Holdings, Inc., a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani shares opened for trading at $11.26. Since then,...
Via
Talk Markets
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
July 30, 2021
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani Shares...
Via
Benzinga
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
Why XOMA Stock Is Trading Higher Wednesday?
July 28, 2021
XOMA Corporation (NASDAQ: XOMA) stock is trading higher during the morning session on robust volume after the FDA granted an Orphan drug tag to NIS793 for...
Via
Benzinga
Exposures
Product Safety
Novartis' TGFβ Targeted Antibody Secures FDA Orphan Drug Tag For Pancreatic Cancer
July 27, 2021
The FDA has granted Orphan Drug Designation to Novartis AG's (NYSE: NVS) NIS793 in combination with standard of care chemotherapy to treat pancreatic...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs, And More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefited from the optimism that was set in motion by the solid start to the pharma reporting...
Via
Talk Markets
Exposures
Product Safety
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Panic Attack
July 21, 2021
The H1 rise in US markets was based on hope for an end to lockdowns.
Via
Talk Markets
Stock Market Rally Rebounds To Highs; Snap, Crocs, Chipotle, Netflix Are Key Earnings
July 23, 2021
The market rally rebounded from Monday, with the S&P 500 hitting a record high. Snap, Crocs, Chipotle were earnings winners
Via
Investor's Business Daily
Topics
Earnings
Stocks
Exposures
Financial
Fossil Fuels
US Equities
Novartis (NVS) Q2 2021 Earnings Call Transcript
July 21, 2021
NVS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Novartis Posts Q2 Earnings Beat As Sales Pick Up; Reiterates 2021 Guidance
July 21, 2021
Novartis AG boosted its second-quarter core net income by 20% Y/Y to $3.7 billion, beating market expectations as it kept its 2021 guidance.
Via
Talk Markets
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
July 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...
Via
Benzinga
Earnings Scheduled For July 21, 2021
July 21, 2021
Companies Reporting Before The Bell Verizon Communications Inc. (NYSE: VZ) is estimated to report quarterly earnings at $1.29 per share on revenue of $32.68 billion. Seagate...
Via
Benzinga
Novartis Earnings Top, Drug Giant's Stock Eyes Key Level
July 21, 2021
Novartis earnings beat Q2 views. The drug giant's stock rose slightly, suggesting a move above a key level.
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings
July 21, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade as the Dow Jones surged around 550 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novartis Posts Q2 Earnings Beat As Sales Pick Up; Reiterates 2021 Guidance
July 21, 2021
Novartis AG (NYSE: NVS) boosted its second-quarter core net income by 20% Y/Y to $3.7 billion, beating market expectations as it kept its 2021 guidance. Earnings:...
Via
Benzinga
Topics
Earnings
Exposures
Financial
AbbVie: High Yield At A Low P/E
July 17, 2021
Over the first half of this year, pharmaceutical giant AbbVie has traded in a narrow range while meme stocks, cryptocurrencies, and other get-rich-quick schemes have diverted investor attention away...
Via
Talk Markets
Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients
July 15, 2021
Incyte Corporation (NASDAQ: INCY) has announced that positive data from the Phase 3 REACH3 study have been published in The New England Journal of Medicine (NEJM...
Via
Benzinga
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Dialing For Stocks
July 14, 2021
Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Cowen Initiates Coverage On Molecular Partners With Price Target Of $50
July 13, 2021
Cowen & Co initiated coverage on Molecular Partners (NASDAQ: MOLN) with an Outperform rating and a Price Target of $50, implying an upside potential of...
Via
Benzinga
Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159
July 12, 2021
Celldex Therapeutics Inc (NASDAQ: CLDX) got a boost Friday with a data readout from Phase 1b trial of CDX-0159 in patients with antihistamine refractory cold...
Via
Benzinga
Recovery Friday
July 09, 2021
The big winners this week were Financials.
Via
Talk Markets
Molecular Partners - Novartis' COVID-19 Antiviral Shows Encouraging Preclinical Action Against Delta Variant
July 08, 2021
Molecular Partners AG (NASDAQ: MOLN) reported on the clinical progress of its antiviral candidate, ensovibep, as part of a presentation with its partner Novartis...
Via
Benzinga
Exposures
COVID-19
Pot Stocks Down In June - Remain +29.6% YTD
July 04, 2021
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Novartis Looks To Enter mRNA Technology, Says Chairman: Reuters
July 01, 2021
Novartis AG (NYSE: NVS) could get into the field of messenger ribonucleic acid (mRNA) technology, reported Reuters, citing Chairman Joerg Reinhardt in a newspaper...
Via
Benzinga
Drug Formulation Developer Aerovate Therapeutics Kick Starts Trading Today With Upsized Debut
June 30, 2021
Just shy of a full year after emerging from stealth mode, Aerovate Therapeutics Inc (NASDAQ: AVTE) is listing onto NASDAQ with an upsized offering. The company ...
Via
Benzinga
Novartis Claims It Overpaid Genentech $210M In Patent Licensing Pact
June 29, 2021
Novartis AG (NYSE: NVS) said it dutifully paid millions to Genentech as part of a patent licensing deal dated back to 2005. But now, Novartis discovered it...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.